Other forms of coccidioidomycosis
ICD-10 B38.89 is a billable code used to indicate a diagnosis of other forms of coccidioidomycosis.
Coccidioidomycosis, commonly known as Valley Fever, is a fungal infection caused by the inhalation of spores from the Coccidioides species, primarily C. immitis and C. posadasii. This condition can manifest in various forms, ranging from asymptomatic to severe pulmonary disease, and can disseminate to other organs, particularly in immunocompromised patients. The 'Other forms of coccidioidomycosis' code (B38.89) is used when the infection presents atypically or when the specific form does not fall under the more commonly recognized categories such as pulmonary or disseminated coccidioidomycosis. Symptoms may include fever, cough, chest pain, and fatigue, but can also involve skin lesions, meningitis, or bone involvement in more severe cases. Diagnosis is typically confirmed through serological tests, culture, or histopathological examination. Treatment often involves antifungal medications such as fluconazole or itraconazole, especially in immunocompromised individuals who are at higher risk for severe disease progression. Close monitoring and follow-up are essential to manage potential complications and ensure effective treatment.
Detailed clinical notes on symptoms, diagnostic tests, and treatment plans.
Patients presenting with respiratory symptoms, fever, or disseminated disease.
Consideration of immunocompromised status and potential for atypical presentations.
Pulmonary function tests, imaging studies, and treatment response documentation.
Patients with chronic cough, pleuritic chest pain, or abnormal chest imaging.
Need for clear documentation of pulmonary involvement and any associated complications.
When a patient presents with symptoms suggestive of coccidioidomycosis.
Document the clinical rationale for testing and results.
Infectious disease specialists should ensure comprehensive documentation of the patient's history and risk factors.
Common symptoms include fever, cough, chest pain, fatigue, and in severe cases, skin lesions or neurological symptoms.
Treatment typically involves antifungal medications such as fluconazole or itraconazole, especially in patients with severe or disseminated disease.
